Literature DB >> 21098240

The antibiotic monensin causes cell cycle disruption of Toxoplasma gondii mediated through the DNA repair enzyme TgMSH-1.

Mark D Lavine1, Gustavo Arrizabalaga.   

Abstract

Monensin is a polyether ionophore antibiotic that is widely used in the control of coccidia in animals. Despite its significance in veterinary medicine, little is known about its mode of action and potential mechanisms of resistance in coccidian parasites. Here we show that monensin causes accumulation of the coccidian Toxoplasma gondii at an apparent late-S-phase cell cycle checkpoint. In addition, experiments utilizing a monensin-resistant T. gondii mutant show that this effect of monensin is dependent on the function of a mitochondrial homologue of the MutS DNA damage repair enzyme (TgMSH-1). Furthermore, the same TgMSH-1-dependent cell cycle disruption is observed with the antiparasitic ionophore salinomycin and the DNA alkylating agent methyl nitrosourea. Our results suggest a novel mechanism for the mode of action of monensin and salinomycin on coccidial parasites, in which the drug activates an MSH-1-dependent cell cycle checkpoint by an unknown mechanism, ultimately leading to the death of the parasite. This model would indicate that cell cycle disruption is an important mediator of drug susceptibility and resistance to ionophoric antibiotics in coccidian parasites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098240      PMCID: PMC3028789          DOI: 10.1128/AAC.01092-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  A role for Saccharomyces cerevisiae histone H2A in DNA repair.

Authors:  J A Downs; N F Lowndes; S P Jackson
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

2.  In vitro activity of the polyether ionophorous antibiotic monensin against the cyst form of Toxoplasma gondii.

Authors:  S Couzinet; J F Dubremetz; D Buzoni-Gatel; G Jeminet; G Prensier
Journal:  Parasitology       Date:  2000-10       Impact factor: 3.234

3.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

Review 4.  Toxoplasma gondii: the model apicomplexan.

Authors:  Kami Kim; Louis M Weiss
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

Review 5.  Signalling cell cycle arrest and cell death through the MMR System.

Authors:  Vincent O'Brien; Robert Brown
Journal:  Carcinogenesis       Date:  2005-12-06       Impact factor: 4.944

6.  MYST family lysine acetyltransferase facilitates ataxia telangiectasia mutated (ATM) kinase-mediated DNA damage response in Toxoplasma gondii.

Authors:  Nathalie Vonlaufen; Arunasalam Naguleswaran; Isabelle Coppens; William J Sullivan
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

7.  Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling.

Authors:  Nathan T Ihle; Ryan Williams; Sherry Chow; Wade Chew; Margareta I Berggren; Gillian Paine-Murrieta; Daniel J Minion; Robert J Halter; Peter Wipf; Robert Abraham; Lynn Kirkpatrick; Garth Powis
Journal:  Mol Cancer Ther       Date:  2004-07       Impact factor: 6.261

8.  Evidence that msh1p plays multiple roles in mitochondrial base excision repair.

Authors:  Leah Pogorzala; Shona Mookerjee; Elaine A Sia
Journal:  Genetics       Date:  2009-04-27       Impact factor: 4.562

Review 9.  Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail.

Authors:  William F Marzluff; Eric J Wagner; Robert J Duronio
Journal:  Nat Rev Genet       Date:  2008-11       Impact factor: 53.242

10.  Forward genetic analysis of the apicomplexan cell division cycle in Toxoplasma gondii.

Authors:  Marc-Jan Gubbels; Margaret Lehmann; Mani Muthalagi; Maria E Jerome; Carrie F Brooks; Tomasz Szatanek; Jayme Flynn; Ben Parrot; Josh Radke; Boris Striepen; Michael W White
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  12 in total

1.  A novel benzodioxole-containing inhibitor of Toxoplasma gondii growth alters the parasite cell cycle.

Authors:  Edwin Kamau; Tracy Meehan; Mark D Lavine; Gustavo Arrizabalaga; Gabriela Mustata Wilson; Jon Boyle
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

Review 2.  Drug target identification in protozoan parasites.

Authors:  Joachim Müller; Andrew Hemphill
Journal:  Expert Opin Drug Discov       Date:  2016-06-16       Impact factor: 6.098

3.  Early Transcriptional Response to Monensin in Sensitive and Resistant Strains of Eimeria tenella.

Authors:  Hongtao Zhang; Lei Zhang; Hongbin Si; Xianyong Liu; Xun Suo; Dandan Hu
Journal:  Front Microbiol       Date:  2022-07-04       Impact factor: 6.064

4.  Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.

Authors:  Sarah D'Alessandro; Yolanda Corbett; Denise P Ilboudo; Paola Misiano; Nisha Dahiya; Solomon M Abay; Annette Habluetzel; Romualdo Grande; Maria R Gismondo; Koen J Dechering; Karin M J Koolen; Robert W Sauerwein; Donatella Taramelli; Nicoletta Basilico; Silvia Parapini
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

5.  Boromycin Has Potent Anti-Toxoplasma and Anti-Cryptosporidium Activity.

Authors:  Jaypee Abenoja; Alexis Cotto-Rosario; Roberta O'Connor
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.938

6.  Human Placental Syncytiotrophoblasts Restrict Toxoplasma gondii Attachment and Replication and Respond to Infection by Producing Immunomodulatory Chemokines.

Authors:  Stephanie E Ander; Elizabeth N Rudzki; Nitin Arora; Yoel Sadovsky; Carolyn B Coyne; Jon P Boyle
Journal:  MBio       Date:  2018-01-09       Impact factor: 7.867

7.  Lack of mitochondrial MutS homolog 1 in Toxoplasma gondii disrupts maintenance and fidelity of mitochondrial DNA and reveals metabolic plasticity.

Authors:  Tamila Garbuz; Gustavo Arrizabalaga
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

8.  Analysis of monensin sensitivity in Toxoplasma gondii reveals autophagy as a mechanism for drug induced death.

Authors:  Mark D Lavine; Gustavo Arrizabalaga
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  Maduramicin inhibits proliferation and induces apoptosis in myoblast cells.

Authors:  Xin Chen; Ying Gu; Karnika Singh; Chaowei Shang; Mansoureh Barzegar; Shanxiang Jiang; Shile Huang
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

10.  Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function.

Authors:  Robert A Charvat; Gustavo Arrizabalaga
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.